In melanoma, Quentin et al. [36] found that most tumor-infiltrating CD8+ T cells express Siglec-9 and that Siglec-9-mediated signaling pathways preferentially bind to SHP-1, inhibiting biological functions, including TCR signaling pathways and cytotoxicity in CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.